Rivaroxaban 366789-02-8 Sisitemu yamaraso irinda Antithrombose
Kwishura:T / T, L / C.
Inkomoko y'ibicuruzwa:Ubushinwa
Icyambu cyo kohereza:Beijing / Shanghai / Hangzhou
Ubushobozi bwo gukora:200kg / ukwezi
Tegeka (MOQ):25kg
Igihe cyo kuyobora:Iminsi y'akazi
Imiterere y'ububiko:Ubitswe ahantu hakonje, humye, ubushyuhe bwicyumba.
Ibikoresho bipakira:ingoma
Ingano yububiko:25kg / ingoma
Amakuru yumutekano:Ntabwo ari ibintu biteje akaga
Intangiriro
Rivaroxaban, ni imiti igabanya ubukana (amaraso yoroheje).Ikoresha mubantu bakuze bafite fibrillation idasanzwe (usibye fibrillation atriale bitewe n'indwara z'umutima wa rubagimpande, na fibrillation atriel nyuma yo gusimbuza umutima) kugabanya ibyago byo guhagarara k'ubwonko na embolisme sisitemu.
Rivaroxaban, ikoreshwa mu kuvura no gukumira amaraso.
Rivaroxaban, ikoreshwa f kubarwayi bakuze barimo kubagwa ikibuno cyangwa gusimbuza ivi kugirango birinde trombose.
Ibisobanuro (EP)
| Ingingo | Ibisobanuro |
| Kugaragara | Ifu yera cyangwa umuhondo |
| Gukemura | Mubyukuri bidashobora gushonga mumazi, gushonga kubuntu muri DMSO, muburyo budashobora gushonga muri Ethanol ya anhydrous no muri heptane. |
| Kumenyekanisha | IR: Spectrum igomba kubahiriza WS |
| HPLC-RT yicyitegererezo munsi yikizamini cya enantiometric kigomba kubahiriza icya WS. | |
| Amazi | ≤0.5% |
| Ivu rya sulfate | ≤0.1% |
| Gutakaza kumisha | ≤0.5% |
| Ibyuma biremereye | ≤20ppm |
| Enantionmer | Umwanda A: ≤0.4% |
| Ibisigisigi | Ethanol: ≤5000ppm Ethyl acetate: 0005000ppm Acetone: ≤5000ppm N, N-Dimethylformamide: 80880ppm Methylene chloride: ≤600ppm Benzene: ≤2ppm |
| Ibintu bifitanye isano | Umwanda B: ≤0.10% Umwanda D: ≤0.10% Umwanda E: ≤0.10% Umwanda F: ≤0.10% Umwanda G: ≤0.10% Umwanda H: ≤0.10% Umwanda I: ≤0.10% Umwanda J: ≤0.10% RVB-4-NJSH: ≤0,10% RVB-ZA: ≤0,10% RVB-BAM: ≤0.10% RVB-ZC: ≤0.10% RVB-HBY: ≤75ppm Ubundi umwanda utazwi: ≤0.10% Umwanda wose: ≤0.3% |
| Ingano nini yo gukwirakwiza | D10: / D50: / D90: / |
| Suzuma (ibintu bidafite imbaraga) | 98.0-102.0 |
